Skip to main content
SpringerLink
Log in

In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: A technical note

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Summary and Conclusions

The present work aimed to characterize transdermal drug delivery systems of pinacidil monohydrate in vivo by monitoring the effect of the TDDS on blood pressure of methyl prednisolone acetate induced hypertensive rats. The blood pressure of rats was measured using a noninvasive rat BP instrument based on cuff tail technique. A significant fall in rat BP (P<.01) was observed in treatment of hypertensive rats with all the formulations, which was maintained for 48 hours. Interformulation comparison revealed that formulation B-4 was the most effective with 37.96% reduction in BP (160.33±4.96 vs 99.44±4.46 mmHg). It was concluded that a single patch application of pinacidil TDDS (B-4) can effectively control hypertension in rats for 2 days. The system holds promise for clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ishii R, Tagawa T, Ishida T, Naruse T. Antihypertensive effects of a new TDS of clonidine in genetic and experimental rats. Arzneimittelforschung. 1996;46:261–268.

    CAS  PubMed  Google Scholar 

  2. Corbo M, Liu JC, Chien YW. Transdermal controlled delivery of propranolol from a multilaminate adhesive device. Pharm Res. 1989;6:753–758.

    Article  CAS  PubMed  Google Scholar 

  3. Kommuru TR, Khan MA, Reddy TK. Effect of chiral enhancers on the permeability of optically active and racemic metoprolol across hairless mouse skin. Chirality. 1999;11:536–540.

    Article  CAS  PubMed  Google Scholar 

  4. Aqil M, Sultana Y, Ali A. Monolithic matrix type transdermal drug delivery systems of metoprolol tartrate: in-vitro characterization. Acta Pharm. 2003;53:119–126.

    CAS  PubMed  Google Scholar 

  5. Spieker C, Vetter H, Liedtke R, Zidek W, Vetter W. Transdermal beta-blocker therapy in essential hypertension. Am J Hypertens. 1988;1:199S-200S.

    Article  CAS  PubMed  Google Scholar 

  6. Shah HS, Tojo K, Chien YW. Transdermal controlled delivery of verapamil: characterization of in vitro skin permeation. Int J Pharm. 1992;86:167–173.

    Article  CAS  Google Scholar 

  7. Dubey BK. Lypophilzed aqueous-based polymer matrices for transdermal delivery of captopril. J Dermatol Sci. 1995;10:191–195.

    Article  CAS  PubMed  Google Scholar 

  8. Rao PR, Diwan PV. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Pharm. 1998;24:327–336.

    Article  CAS  PubMed  Google Scholar 

  9. Thacharodi D, Rao KP. Transdermal absorption of nifedipine from microemulsions of lipophillic skin penetration enhancers. Int J Pharm. 1994;111:235–240.

    Article  CAS  Google Scholar 

  10. Aqil M, Ali A. Effect of penetration enhancers on transdermal delivery of pinacidil monohydrate. J Sci Pharm. 2002;3:68–71.

    Google Scholar 

  11. McBurney A, Farrow PR, Ainsworth S, Ward JW. Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following iv and oral administration in healthy volunteers. Br J Clin Pharmacol. 1985;19:91–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Dollery C. Pinacidil Monohydrate (monograph). Therapeutic Drugs. New York, NY: Churchill Livingstone; 1991;115–118.

    Google Scholar 

  13. Aqil M, Ali A. Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in-vitro characterization. Eur J Pharm Biopharm. 2002;54:161–164.

    Article  CAS  PubMed  Google Scholar 

  14. Krakoff LR, Selvadurai R, Sytter E. Effect of methylprednisolone upon arterial pressure and the renin angiotensin system in the rat. Am J Physiol. 1975;228:613–617.

    CAS  PubMed  Google Scholar 

  15. Plotz C, Knowlton A, Ragan C. The nature and history of Cushing’s syndrome. Am J Med. 1952;13:597–611.

    Article  CAS  PubMed  Google Scholar 

  16. Soffer LJ, Iannaccone A, Gabrilove JL. Cushing’s syndrome: a study of 50 patients. Am J Med. 1961;30:129–134.

    Article  Google Scholar 

  17. David DS, Grieco MH, Cushman P Jr. Adrenal glucocorticoids after 20 years: a review of their clinically relevant consequences. J Chronic Dis. 1970;22:637–648.

    Article  CAS  PubMed  Google Scholar 

  18. Ragan C. Corticotrophin, cortisone and related steroids in clinical medicine practical considerations. Bull-N. Acad Med. 1973; 29:355–364.

    Google Scholar 

  19. Kotiyan PN, Vavia PR. Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol. Eur J Pharm Biopharm. 2001;52:173–180.

    Article  CAS  PubMed  Google Scholar 

  20. Rao PR, Reddy MN, Ramakrishna S, Diwan PV. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits. Eur J Pharm Biopharm. 2003;56:81–85.

    Article  PubMed  Google Scholar 

  21. Guyot M, Fawaz F. Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. Int J Pharm. 2000; 204:171–182.

    Article  CAS  PubMed  Google Scholar 

  22. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulasion for topical delivery of triptolide. Eur J Pharm Biopharm. 2003;56:189–196.

    Article  CAS  PubMed  Google Scholar 

  23. Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci. 1995;84:312–317.

    Article  CAS  PubMed  Google Scholar 

  24. Yoneto K, Li SK, Higuchi WI, Shimabayashi S. Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J Pharm Sci. 1998;87:209–214.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, 110 062, New Delhi, India

    Mohd Aqil & Asgar Ali

  2. Department of Pharmacology, Faculty of Pharmacy, Hamdard University, 110 062, New Delhi, India

    Yasmin Sultana, Kiran Dubey, Abul K. Najmi & Kollapa K. Pillai

Authors
  1. Mohd Aqil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asgar Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasmin Sultana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kiran Dubey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abul K. Najmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kollapa K. Pillai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohd Aqil.

Additional information

Publised: January 13, 2006

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aqil, M., Ali, A., Sultana, Y. et al. In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: A technical note. AAPS PharmSciTech 7, 6 (2006). https://doi.org/10.1208/pt070106

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/pt070106

Keywords

Search

Navigation